Researcher Spotlight: Andrew Ip, MD
Winship Abnormal cell growth that cannot be controlled by the body's natural defenses. Cancerous cells can grow and eventually form tumors. Institute
For many lymphoma subtypes, a Spongy material found inside the bones containing stem cells that develop into three types of cells: red blood cells that deliver oxygen to the body and take away carbon dioxide; white blood cells that protect the body from infection; and platelets transplant is the recommended treatment strategy following A disease that reappears or grows again after a period of remission.. Previous research has also suggested that lymphoma patients who engage in physical activity during their treatment have better outcomes. However, no one has yet studied whether physical activity during the period of a bone marrow transplant improves outcomes for lymphoma patients. Dr. Ip’s LCRMP project will look at this question, asking patients to agree to a certain level of physical activity (including walking) during their transplant and providing smart watches to monitor and verify this activity. “This study will strive to show a cause and effect between physical activity, quality of life, and outcomes such as less time in the hospital, less complications after treatment, and improved One of the body's defense mechanisms. All lymphomas are a disease of the immune system. recovery,” Dr. Ip says.
Dr. Ip received his MD from Jefferson Medical College in Pennsylvania before moving to Emory University for his residency. Currently a hematology/oncology fellow at Emory, Dr. Ip expects to complete an MSc in Clinical Research in May 2019. Inspired to a scientific career by his parents, who work in the pharmaceutical industry, he became interested in lymphoma research during residency, when assigned to a rotation with Drs. Chris Flowers (an LRF Scientific Advisory Board member) and Jonathon Cohen (a past LCRMP participant himself). He credits Dr. Flowers with inspiring his current project, saying, “I specifically remember Dr. Flowers telling me that he always had an interest in investigating the effect of exercise on lymphoma patients’ outcomes, but never had time. As a junior investigator, I took that as an opportunity to seize!”
Dr. Ip adds that his participation in the LCRMP “has been a fantastic foundation to help jumpstart my career as a young lymphoma investigator. The connections I have made and the assistance in my project development has have been invaluable for my research progress. I believe this will set me up for future success in my career as most of cancer research is collaborative across institutions and in team science.”